Global Patent Medicine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

June 2021 | 101 pages | ID: GE03906DD3AEN
GlobalInfoResearch

Abstracts

The Patent Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Patent Medicine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Patent Medicine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Patent Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Product Patents
• Process Patents

Market segment by Application can be divided into

• Adult
• Children

The key market players for global Patent Medicine market are listed below:

• Pfizer Inc.
• Otsuka Pharmaceutical
• Merck
• Novartis
• Sanofi-Aventis
• Bristol-Myers Squibb Co.
• GSK

Market segment by Region, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Patent Medicine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Patent Medicine, with price, sales, revenue and global market share of Patent Medicine in 2018 and 2019.

Chapter 3, the Patent Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Patent Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Patent Medicine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Patent Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Patent Medicine Introduction
1.2 Market Analysis by Type
  1.2.1 Overview: Global Patent Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
  1.2.2 Product Patents
  1.2.3 Process Patents
1.3 Market Analysis by Application
  1.3.1 Overview: Global Patent Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
  1.3.2 Adult
  1.3.3 Children
1.4 Global Patent Medicine Market Size & Forecast
  1.4.1 Global Patent Medicine Sales in Value (2016-2026))
  1.4.2 Global Patent Medicine Sales in Volume (2016-2026)
  1.4.3 Global Patent Medicine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Patent Medicine Production Capacity Analysis
  1.5.1 Global Patent Medicine Total Production Capacity (2016-2026)
  1.5.2 Global Patent Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
  1.6.1 Patent Medicine Market Drivers
  1.6.2 Patent Medicine Market Restraints
  1.6.3 Patent Medicine Trends Analysis

2 MANUFACTURERS PROFILES

2.1 Pfizer Inc.
  2.1.1 Pfizer Inc. Details
  2.1.2 Pfizer Inc. Major Business
  2.1.3 Pfizer Inc. Patent Medicine Product and Services
  2.1.4 Pfizer Inc. Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Otsuka Pharmaceutical
  2.2.1 Otsuka Pharmaceutical Details
  2.2.2 Otsuka Pharmaceutical Major Business
  2.2.3 Otsuka Pharmaceutical Patent Medicine Product and Services
  2.2.4 Otsuka Pharmaceutical Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Merck
  2.3.1 Merck Details
  2.3.2 Merck Major Business
  2.3.3 Merck Patent Medicine Product and Services
  2.3.4 Merck Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Novartis
  2.4.1 Novartis Details
  2.4.2 Novartis Major Business
  2.4.3 Novartis Patent Medicine Product and Services
  2.4.4 Novartis Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sanofi-Aventis
  2.5.1 Sanofi-Aventis Details
  2.5.2 Sanofi-Aventis Major Business
  2.5.3 Sanofi-Aventis Patent Medicine Product and Services
  2.5.4 Sanofi-Aventis Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bristol-Myers Squibb Co.
  2.6.1 Bristol-Myers Squibb Co. Details
  2.6.2 Bristol-Myers Squibb Co. Major Business
  2.6.3 Bristol-Myers Squibb Co. Patent Medicine Product and Services
  2.6.4 Bristol-Myers Squibb Co. Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 GSK
  2.7.1 GSK Details
  2.7.2 GSK Major Business
  2.7.3 GSK Patent Medicine Product and Services
  2.7.4 GSK Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 PATENT MEDICINE SALES BY MANUFACTURER

3.1 Global Patent Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Patent Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Patent Medicine
3.4 Market Concentration Rate
  3.4.1 Top 3 Patent Medicine Manufacturer Market Share
  3.4.2 Top 6 Patent Medicine Manufacturer Market Share
3.5 Global Patent Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Patent Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 MARKET ANALYSIS BY REGION

4.1 Global Patent Medicine Market Size by Region
  4.1.1 Global Patent Medicine Sales in Volume by Region (2016-2026)
  4.1.2 Global Patent Medicine Revenue by Region (2016-2026)
4.2 North America Patent Medicine Revenue (2016-2026)
4.3 Europe Patent Medicine Revenue (2016-2026)
4.4 Asia-Pacific Patent Medicine Revenue (2016-2026)
4.5 South America Patent Medicine Revenue (2016-2026)
4.6 Middle East and Africa Patent Medicine Revenue (2016-2026)

5 MARKET SEGMENT BY TYPE

5.1 Global Patent Medicine Sales in Volume by Type (2016-2026)
5.2 Global Patent Medicine Revenue by Type (2016-2026)
5.3 Global Patent Medicine Price by Type (2016-2026)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Patent Medicine Sales in Volume by Application (2016-2026)
6.2 Global Patent Medicine Revenue by Application (2016-2026)
6.3 Global Patent Medicine Price by Application (2016-2026)

7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 North America Patent Medicine Sales by Type (2016-2026)
7.2 North America Patent Medicine Sales by Application (2016-2026)
7.3 North America Patent Medicine Market Size by Country
  7.3.1 North America Patent Medicine Sales in Volume by Country (2016-2026)
  7.3.2 North America Patent Medicine Revenue by Country (2016-2026)
  7.3.3 United States Market Size and Forecast (2016-2026)
  7.3.4 Canada Market Size and Forecast (2016-2026)
  7.3.5 Mexico Market Size and Forecast (2016-2026)

8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

8.1 Europe Patent Medicine Sales by Type (2016-2026)
8.2 Europe Patent Medicine Sales by Application (2016-2026)
8.3 Europe Patent Medicine Market Size by Country
  8.3.1 Europe Patent Medicine Sales in Volume by Country (2016-2026)
  8.3.2 Europe Patent Medicine Revenue by Country (2016-2026)
  8.3.3 Germany Market Size and Forecast (2016-2026)
  8.3.4 France Market Size and Forecast (2016-2026)
  8.3.5 United Kingdom Market Size and Forecast (2016-2026)
  8.3.6 Russia Market Size and Forecast (2016-2026)
  8.3.7 Italy Market Size and Forecast (2016-2026)

9 ASIA-PACIFIC BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 Asia-Pacific Patent Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Patent Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Patent Medicine Market Size by Region
  9.3.1 Asia-Pacific Patent Medicine Sales in Volume by Region (2016-2026)
  9.3.2 Asia-Pacific Patent Medicine Revenue by Region (2016-2026)
  9.3.3 China Market Size and Forecast (2016-2026)
  9.3.4 Japan Market Size and Forecast (2016-2026)
  9.3.5 Korea Market Size and Forecast (2016-2026)
  9.3.6 India Market Size and Forecast (2016-2026)
  9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
  9.3.8 Australia Market Size and Forecast (2016-2026)

10 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 South America Patent Medicine Sales by Type (2016-2026)
10.2 South America Patent Medicine Sales by Application (2016-2026)
10.3 South America Patent Medicine Market Size by Country
  10.3.1 South America Patent Medicine Sales in Volume by Country (2016-2026)
  10.3.2 South America Patent Medicine Revenue by Country (2016-2026)
  10.3.3 Brazil Market Size and Forecast (2016-2026)
  10.3.4 Argentina Market Size and Forecast (2016-2026)

11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

11.1 Middle East & Africa Patent Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Patent Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Patent Medicine Market Size by Country
  11.3.1 Middle East & Africa Patent Medicine Sales in Volume by Country (2016-2026)
  11.3.2 Middle East & Africa Patent Medicine Revenue by Country (2016-2026)
  11.3.3 Turkey Market Size and Forecast (2016-2026)
  11.3.4 Egypt Market Size and Forecast (2016-2026)
  11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
  11.3.6 South Africa Market Size and Forecast (2016-2026)

12 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

12.1 Sales Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
12.2 Patent Medicine Typical Distributors
12.3 Patent Medicine Typical Customers

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Patent Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Patent Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Patent Medicine Product and Services
Table 6. Pfizer Inc. Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Otsuka Pharmaceutical Major Business
Table 9. Otsuka Pharmaceutical Patent Medicine Product and Services
Table 10. Otsuka Pharmaceutical Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Patent Medicine Product and Services
Table 14. Merck Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Patent Medicine Product and Services
Table 18. Novartis Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi-Aventis Major Business
Table 21. Sanofi-Aventis Patent Medicine Product and Services
Table 22. Sanofi-Aventis Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol-Myers Squibb Co. Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Co. Major Business
Table 25. Bristol-Myers Squibb Co. Patent Medicine Product and Services
Table 26. Bristol-Myers Squibb Co. Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GSK Basic Information, Manufacturing Base and Competitors
Table 28. GSK Major Business
Table 29. GSK Patent Medicine Product and Services
Table 30. GSK Patent Medicine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Patent Medicine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 32. Global Patent Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Patent Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Patent Medicine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 35. Head Office and Patent Medicine Production Site of Key Manufacturer
Table 36. Patent Medicine New Entrant and Capacity Expansion Plans
Table 37. Patent Medicine Mergers & Acquisitions in the Past Five Years
Table 38. Global Patent Medicine Sales by Region (2016-2021e) & (K Doses)
Table 39. Global Patent Medicine Sales by Region (2021-2026) & (K Doses)
Table 40. Global Patent Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Patent Medicine Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Patent Medicine Sales by Type (2016-2021e) & (K Doses)
Table 43. Global Patent Medicine Sales by Type (2021-2026) & (K Doses)
Table 44. Global Patent Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Patent Medicine Price by Type (2016-2021e) & (USD/Dose)
Table 47. Global Patent Medicine Price by Type (2021-2026) & (USD/Dose)
Table 48. Global Patent Medicine Sales by Application (2016-2021e) & (K Doses)
Table 49. Global Patent Medicine Sales by Application (2021-2026) & (K Doses)
Table 50. Global Patent Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Patent Medicine Price by Application (2016-2021e) & (USD/Dose)
Table 53. Global Patent Medicine Price by Application (2021-2026) & (USD/Dose)
Table 54. North America Patent Medicine Sales by Country (2016-2021e) & (K Doses)
Table 55. North America Patent Medicine Sales by Country (2021-2026) & (K Doses)
Table 56. North America Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Patent Medicine Sales by Type (2016-2021e) & (K Doses)
Table 59. North America Patent Medicine Sales by Type (2021-2026) & (K Doses)
Table 60. North America Patent Medicine Sales by Application (2016-2021e) & (K Doses)
Table 61. North America Patent Medicine Sales by Application (2021-2026) & (K Doses)
Table 62. Europe Patent Medicine Sales by Country (2016-2021e) & (K Doses)
Table 63. Europe Patent Medicine Sales by Country (2021-2026) & (K Doses)
Table 64. Europe Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Patent Medicine Sales by Type (2016-2021e) & (K Doses)
Table 67. Europe Patent Medicine Sales by Type (2021-2026) & (K Doses)
Table 68. Europe Patent Medicine Sales by Application (2016-2021e) & (K Doses)
Table 69. Europe Patent Medicine Sales by Application (2021-2026) & (K Doses)
Table 70. Asia-Pacific Patent Medicine Sales by Region (2016-2021e) & (K Doses)
Table 71. Asia-Pacific Patent Medicine Sales by Region (2021-2026) & (K Doses)
Table 72. Asia-Pacific Patent Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Patent Medicine Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Patent Medicine Sales by Type (2016-2021e) & (K Doses)
Table 75. Asia-Pacific Patent Medicine Sales by Type (2021-2026) & (K Doses)
Table 76. Asia-Pacific Patent Medicine Sales by Application (2016-2021e) & (K Doses)
Table 77. Asia-Pacific Patent Medicine Sales by Application (2021-2026) & (K Doses)
Table 78. South America Patent Medicine Sales by Country (2016-2021e) & (K Doses)
Table 79. South America Patent Medicine Sales by Country (2021-2026) & (K Doses)
Table 80. South America Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Patent Medicine Sales by Type (2016-2021e) & (K Doses)
Table 83. South America Patent Medicine Sales by Type (2021-2026) & (K Doses)
Table 84. South America Patent Medicine Sales by Application (2016-2021e) & (K Doses)
Table 85. South America Patent Medicine Sales by Application (2021-2026) & (K Doses)
Table 86. Middle East & Africa Patent Medicine Sales by Country (2016-2021e) & (K Doses)
Table 87. Middle East & Africa Patent Medicine Sales by Country (2021-2026) & (K Doses)
Table 88. Middle East & Africa Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Patent Medicine Sales by Type (2016-2021e) & (K Doses)
Table 91. Middle East & Africa Patent Medicine Sales by Type (2021-2026) & (K Doses)
Table 92. Middle East & Africa Patent Medicine Sales by Application (2016-2021e) & (K Doses)
Table 93. Middle East & Africa Patent Medicine Sales by Application (2021-2026) & (K Doses)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Patent Medicine Typical Distributors
Table 97. Patent Medicine Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Patent Medicine Picture
Figure 2. Global Patent Medicine Sales Market Share by Type in 2020
Figure 3. Product Patents
Figure 4. Process Patents
Figure 5. Global Patent Medicine Sales Market Share by Application in 2020
Figure 6. Adult
Figure 7. Children
Figure 8. Global Patent Medicine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Patent Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Patent Medicine Sales (2016-2026) & (K Doses)
Figure 11. Global Patent Medicine Price by Type (2016-2026) & (USD/Dose)
Figure 12. Global Patent Medicine Production Capacity (2016-2026) & (K Doses)
Figure 13. Global Patent Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Patent Medicine Market Drivers
Figure 15. Patent Medicine Market Restraints
Figure 16. Patent Medicine Market Trends
Figure 17. Global Patent Medicine Sales Market Share by Manufacturer in 2020
Figure 18. Global Patent Medicine Revenue Market Share by Manufacturer in 2020
Figure 19. Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Patent Medicine Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Patent Medicine Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Patent Medicine Sales Market Share by Region (2016-2026)
Figure 23. Global Patent Medicine Revenue Market Share by Region (2016-2026)
Figure 24. North America Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 25. Europe Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 27. South America Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 29. Global Patent Medicine Sales Market Share by Type (2016-2026)
Figure 30. Global Patent Medicine Revenue Market Share by Type (2016-2026)
Figure 31. Global Patent Medicine Price by Type (2016-2026) & (USD/Dose)
Figure 32. Global Patent Medicine Sales Market Share by Application (2016-2026)
Figure 33. Global Patent Medicine Revenue Market Share by Application (2016-2026)
Figure 34. Global Patent Medicine Price by Application (2016-2026) & (USD/Dose)
Figure 35. North America Patent Medicine Sales Market Share by Type (2016-2026)
Figure 36. North America Patent Medicine Sales Market Share by Application (2016-2026)
Figure 37. North America Patent Medicine Sales Market Share by Country (2016-2026)
Figure 38. North America Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 39. United States Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Patent Medicine Sales Market Share by Type (2016-2026)
Figure 43. Europe Patent Medicine Sales Market Share by Application (2016-2026)
Figure 44. Europe Patent Medicine Sales Market Share by Country (2016-2026)
Figure 45. Europe Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 46. Germany Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Patent Medicine Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Patent Medicine Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Patent Medicine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Patent Medicine Revenue Market Share by Region (2016-2026)
Figure 55. China Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Patent Medicine Sales Market Share by Type (2016-2026)
Figure 62. South America Patent Medicine Sales Market Share by Application (2016-2026)
Figure 63. South America Patent Medicine Sales Market Share by Country (2016-2026)
Figure 64. South America Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Patent Medicine Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Patent Medicine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Patent Medicine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source